Cancer Gene Therapy Market Trends: Advances in Gene Editing and Delivery Systems
The latest research report released by Polaris Market Research titled Cancer Gene Therapy Market Opportunity offers a thorough assessment of a rapidly growing market. It covers all the major market aspects, including market share, size, trends, and major market developments. In addition, a thorough assessment of the key market opportunities, market restraints, and challenges has been provided. The research report has been prepared by expert researchers and experienced analysts who have vast experience in the market.
The report sheds light on major market players, market segments, and geographic landscape. Also, an assessment of the cost structure, and product landscape and price has been included in the study. The research report makes use of quantitative and qualitative analysis, along with graphical representations such as charts, tables, and graphs, to provide a comprehensive market analysis. The report is a must-have for businesses, investors, and stakeholders looking to develop effective operating strategies in the Cancer Gene Therapy market.
Market Stats
Global Gene Therapy Market size and share is currently valued at USD 2,251.50 million in 2024 and is anticipated to generate an estimated revenue of USD 27,250.20 million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 27.1% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034
Market Dynamics
Market Drivers
The study shares crucial information on various market factors, including growth drivers, financial data, and development patterns. In addition, information on innovations and the latest technologies has been included. The Cancer Gene Therapy market report has been prepared by considering the market’s evolving nature. It sheds light on demand and supply trends and the major factors contributing to the products/services demand in the market. A thorough assessment of major market trends and opportunities has been provided in the report.
Market Restraints
The research report identifies risks, challenges, and threats that may impede the market growth in the coming years. Knowing these market restraints is crucial as it informs stakeholders about the potential market barriers. By going through the information, businesses can effectively address these issues and capitalize on emerging market opportunities. In addition, the information will enable stakeholders to make more informed decisions.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market
Some of the top market players are:
Bluebird Bio
Bristol Myers Squibb
Gilead Sciences Inc
GlaxoSmithKline
Novartis AG
Sangamo Biosciences
Spark Therapeutics LLC
Ultragenyx
Voyager Therapeutics
Regional Analysis
The research report discusses the Cancer Gene Therapy market growth across various regions and sub-regions. The regional analysis has been done by analyzing the market at the national, regional, and global levels by various market segments. Also, an assessment of the market’s historical performance in specific regions and their logisitics, supply and demand, and production capacity has been provided. The study also includes forecast analysis covering important information about revenue projection, global production, and regional forecasts.
A few of the key regions and sub-regions covered in the market research report are:
• North America (US, Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Argentina, and Rest of Latin America)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of Middle East & Africa)
Segmental Overview
This report section divides the market into various groups tied together by similarities. By going through the Cancer Gene Therapy market segmentation section, businesses can devise effective strategies tailored to each of these market groups. In addition, stakeholders can align their objectives and market channels with high precision. Segmental analysis can help stakeholders focus their resources on the most promising market segments. Businesses can gain a better understanding of shifting market trends and apply data-driven go-to-market strategies. What’s more, businesses can develop services, products, or new features that will cater to every segment.
Recent Developments
September 2022 – GlaxoSmithKline (GSK) presented insights on the role of Zejula and Jemperli in cancer treatment at ESMO. Additionally, GSK and iTeos announced plans to initiate a study on dostarlimab, a recently approved cancer drug, to further explore its therapeutic potential.
June 2022 – ImmunoAct completed its Phase 1 clinical trials for CAR-T (Chimeric Antigen Receptor) therapy, designed to treat specific cancer types. Notably, the treatment is projected to cost one-tenth of the standard CAR-T therapy price in India, making it a more affordable option for patients.
August 2022 – Bristol Myers Squibb finalized the acquisition of Turning Point Therapeutics, a company specializing in oncology innovations. This acquisition is expected to strengthen Bristol Myers Squibb’s position in the oncology market.
March 2021 – Bristol Myers Squibb and Bluebird Bio received FDA approval for Abecma, a cell-based therapy for cancer treatment. The companies are also developing an Opdivo-based combination therapy to enhance cancer treatment options.
April 2024 – India introduced its first natively developed CAR-T cell therapy, actalycabtagene autoleucel. The therapy was developed through a collaboration between Tata Memorial Hospital, the Indian Institute of Technology (IIT) Bombay, and ImmunoACT, marking a major milestone in India’s cancer treatment advancements.
June 2024 – The FDA granted accelerated approval to a combination of adagrasib and cetuximab for adults with KRAS G12C-mutated colorectal cancer. Eligible patients must have previously undergone treatment with oxaliplatin-, fluoropyrimidine-, and irinotecan-based chemotherapy, as determined by an FDA-approved test.
The Report Answers Questions Such As
• What are the major changes in Cancer Gene Therapy market dynamics and competitive landscape in recent years?
• What are the challenges and restraining factors of the market?
• Which region accounted for the largest market share in the market?
• Which segment is projected to witness the fastest growth during the forecast period?
• What are the emerging trends market participants can capitalize on?
• How can businesses create effective sales and marketing strategies?
More Trending Latest Reports By Polaris Market Research:
Home Fragrance Diffuser Market
Next Generation Emergency Response System Market
Plant-Based Leather Market
Automotive Cold-End Exhaust Aftermarket
Generative AI Coding Assistants Market
Ready-To-Drink Cocktails Market
5G Enterprise Market
Cbd Oil Market
Non-meat Ingredients Market
Comments
0 comment